IL2 and atherosclerosis: RYR2 regulates T-cell calcium signaling, and gain-of-function mutations lead to increased IL-2 secretion in CD4+ T cells, which is a novel immune cell infiltration-related biomarker in atherosclerosis diagnosis (60).